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The Circadian Clock Gene Period1 Connects
the Molecular Clock to Neural Activity in
the Suprachiasmatic Nucleus
Takashi Kudo1, Gene D. Block1, and Christopher S. Colwell1
Abstract
The neural activity patterns of suprachiasmatic nucleus (SCN) neurons are dynamically regulated throughout the circadian
cycle with highest levels of spontaneous action potentials during the day. These rhythms in electrical activity are critical for
the function of the circadian timing system and yet the mechanisms by which the molecular clockwork drives changes in the
membrane are not well understood. In this study, we sought to examine how the clock gene Period1 (Per1) regulates the
electrical activity in the mouse SCN by transiently and selectively decreasing levels of PER1 through use of an antisense
oligodeoxynucleotide. We found that this treatment effectively reduced SCN neural activity. Direct current injection to
restore the normal membrane potential partially, but not completely, returned firing rate to normal levels. The antisense
treatment also reduced baseline [Ca2þ]i levels as measured by Fura2 imaging technique. Whole cell patch clamp recording
techniques were used to examine which specific potassium currents were altered by the treatment. These recordings
revealed that the large conductance [Ca2þ]i-activated potassium currents were reduced in antisense-treated neurons and
that blocking this current mimicked the effects of the anti-sense on SCN firing rate. These results indicate that the circadian
clock gene Per1 alters firing rate in SCN neurons and raise the possibility that the large conductance [Ca2þ]i-activated
channel is one of the targets.
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Introduction
Robust circadian rhythms are important to our health
and wellness. Mechanistically, many cells within our
body express circadian rhythms in cellular functioning
that are generated by autoregulatory loops involving
transcription, translation, and degradation of key clock
genes. These rhythms have an endogenous periodicity of
approximately 24 h (Hogenesch and Ueda, 2011; Brown
et al., 2012; Buhr and Takahashi, 2013). Moreover, our
bodies comprise an extensive network of circadian oscil-
lators, with each of the major organ systems (e.g., heart,
liver, pancreas) apparently having its own clockwork to
regulate the transcription of genes that are important to
the specific target organ (Dibner et al., 2010). These cir-
cadian rhythms are largely synchronized by central pace-
maker neurons located in a small subset of cells in the
hypothalamus of the central nervous system—known as
the suprachiasmatic nucleus (SCN). These pacemaker
neurons exhibit circadian rhythms in spontaneous firing
rates (SFRs) which, as evidence indicates, are critical as
an output for the circadian system (Colwell, 2011).
Previous studies implicate the molecular clockwork of
SCN neurons in driving circadian rhythms in SCN
electrical activity. For example, the Tau (Casein kinase
1e) mutation in hamsters shortens the period of
wheel-running activity and neural activity rhythms
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(Liu et al., 1997). Similarly, homozygoteClockmutant mice
are behaviorally arrhythmic, while heterozygote animals
show lengthened behavioral rhythms, findings that are par-
alleled by physiological recordings from the SCN (Herzog
et al., 1998; Nakamura et al., 2002). Furthermore, Cry1/2
double mutants show behavioral arrhythmicity and loss of
rhythms in SCN neural activity (Albus et al., 2002). These
correlative findings suggest that clock gene rhythms are
translated into daily patterns of action potential activity in
the SCN.However, themechanisms bywhich themolecular
clock regulates SCN neural activity are not known and are
the focus of our present work.
In this study, we utilized antisense oligodeoxynucleo-
tide (ODN) against Period1 (Per1) as a tool to transiently
suppress PER1 protein. We first confirmed that the treat-
ment was selective and established a time course for the
transient reduction in protein. Next, we determined the
impact of the treatment on SFR and resting [Ca2þ]i levels
in SCN neurons. Finally, we measured the impact of the
antisense treatment on three potassium currents known
to modulate neural activity in the SCN including the fast
delayed rectifier (FDR), A-type (IA), and large conduct-
ance [Ca2þ]i-activated (BK) currents. The results indicate
that circadian clock gene Per1 rapidly alters the neural
activity of SCN neurons and suggests that the BK current
may be responsible.
Material and Methods
Ethical Approval
The experimental protocols used in this study were
approved by the University of California, Los Angeles
(UCLA) Animal Research Committee, and all recommen-
dations for animal use and welfare, as dictated in the
UCLA Division of laboratory Animals and the guidelines
from the National Institutes of Health, were followed.
Animals
We obtained C57BL/6 mice from breeding colonies at
UCLA. For bioluminescence experiments, C57Bl/6
PER2::LUC knock-in mice (backcrossed for a minimum
of 12 generations; Yoo et al., 2004) were used. Starting at
3 weeks of age, the mice were placed in chambers where
lights came on at 9:00 a.m. and off at 9:00 p.m. (tempera-
ture, 22 2C). This LD cycle was used throughout the
study with zeitgeber time (ZT) 0 defined as the time that
the lights came on. Food and water were supplied ad
libitum. Totally, 387 mice were used in this study.
Brain Slice Preparation
Methods utilized were similar to those described previ-
ously (Kudo et al., 2011, 2013, 2014). Brain slices were
prepared with standard techniques from mice (C57BL/6,
PER2::LUC) at 1 month of age with mice killed at ZT 0.
Mice were anesthetized by Isoflurane (Phoenix
Pharmaceutical, Burlingame, CA) anesthesia and rapidly
decapitated. To prepare SCN cultures, the brain was
excised from skull and placed in chilled low Ca2þ
ACSF [in mM: 26NaHCO3, 1.25NaH2PO4, 10 glucose,
125NaCl, 3KCl, 5MgCl2, and 1CaCl2, pH 7.2–7.4
(290–310mOsm)]. After chilling, the brains were trimmed
to a block containing the hypothalamus and optic nerves.
The brain was sliced in coronal plane on a vibratome
(Leica Microsystems, Buffalo Grove, IL) at a thickness
of 200mm. The slice was then trimmed to 4 4-mm
squares, transferred directly to culture membranes
(Merck Millipore, Darmstadt, Germany) in 35-mm culture
dishes with 1ml of MEM (Invitrogen, Carlsbad, CA) con-
taining 30mM HEPES, 20mMD-glucose, 5% B27, 5mM
L-glutamine, and 25 U ml1 streptomycin–penicillin, and
maintained at 34C and 5% CO2 (Han et al., 2006).
Immunohistochemistry
Mouse SCN slices were made with the same method
described earlier (see Supplemental Figure 1 for immuno-
histochemistry [IHC] protocol). The SCN was fixed at ZT
2, 3, 4, 5, and 6, and PER1 expression was examined. The
slices were fixed by 4% paraformaldehyde (Sigma-
Aldrich) in phosphate-buffered saline (PBS; pH 7.4) at
ZT 2, 3, 4, 5, and 6. After that the slices were fixed at
4C overnight and cryoprotected in 20% sucrose in PBS.
IHC was performed on free-floating 20 mm cryostat
(Thermo Fisher Scientific, Carlsbad, CA) coronal brain
sections. Sections were then washed for 5min with PBS (3
times) and dipped in 3% normal goat serum in PBS with
0.1% Triton X-100 for 1 h. Sections were incubated with
PER1 (1:500; Thermo Fisher Scientific) or PER2 (1:400;
Merck Millipore) antibody for 72 h at 4C. PER2 anti-
body was established by LeSauter et al. (2012). Sections
were rinsed 3 times (5min) in PBS and incubated for 2 h
with an Alexa Fluor 488 goat anti-rabbit IgG (Thermo
Fisher Scientific) diluted 1:200 with Triton X-100-PBS
with 3% normal goat serum. After incubation, sections
were rinsed in TBS 3 times (5min) and immediately
mounted on slides. Sections were then dried and cover-
slipped. Then sections were imaged on the Axio Vision
camera systems (Apotome, Carl Zeiss Microscopy,
Thornwood, NY). Four sections from each slice were
chosen and images were taken. Immune-positive cells
within the SCN were counted manually at 40 with the
aid of a grid. All immune-positive cells within the grid
were counted equally without regard to the intensity of
the staining. Counts were performed by two observers
blind to the treatment protocol, and the results were aver-
aged. Relative optical density in the SCN was measured
using Image J (NIH, Bethesda, MD) software.
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Western Blotting
Methods used were similar to those described previously
(Wang et al., 2009). Mouse SCN slices were made with
the same method described earlier (see Supplemental
Figure 1 for Western blot protocol). SCN were flash
frozen in 50 ml of ice-cold homogenization buffer with
protease inhibitors (Protease Inhibitors complete; Roche
Molecular Biochemicals) at ZT 5. Protein concentration
of the homogenized tissue was determined using the
Figure 1. Antisense ODN for Per1 reduced PER1 expression in the SCN. (a) Photomicrographs illustrate that the application of antisense
ODN for Per1 (10mM) reduces PER1 expression as measured by immunohistochemistry (IHC). Cont: control, Anti: antisense ODN for
Per1, and Scr: scrambled ODN. Bottom right, bar graphs show PER1 positive cell counts for Cont, Anti, and Scr (SE, n¼ 3 for each time
point). *Significant difference (p< .05) analyzed by two-way ANOVA followed by Holm-Sidak method for multiple comparisons (vs. Cont).
ZT¼Zeitgeber time. (b) Example of Western blots measuring PER1 expression in the SCN tissue. Tubulin protein expression was
measured as a control for loading. Bottom: Levels of PER1 protein expression (þSE, normalized to tubulin, n¼ 3 for each group).
*Significant difference (p< .05) analyzed by one-way ANOVA followed by Holm-Sidak method for multiple comparisons (vs. Cont). (c)
Example of Western blots measuring PER2 expression in the SCN tissue. Tubulin protein expression was measured as a control for loading.
Bottom: Levels of PER2 protein expression (þSE, normalized to tubulin, n¼ 3 for each group).
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Bio-Rad Protein assay kit (Bio-Rad, Hercules, CA).
Protein (8 mg) was electrophoresed on SDS/PAGE (15%
gels), transferred on to nitrocellulose membranes, and
probed with primary antibody (PER1 1:500, PER2
1:400, or tubulin 1: 2500, Merck KGaA) overnight.
PER1 antibody is polyclonal antibody (catalog # PA1-
524), and the original antibody epitope is
PSLADDTDANSN. This antibody was used for
Western blotting in several studies (Chilov et al., 2001;
Gillespie et al., 2003; Muhlbauer et al., 2004; Shirogane
et al., 2005; Muhlbauer et al., 2009; Gumz et al., 2010).
The membranes were incubated with horseradish peroxi-
dase-conjugated anti-mouse or anti-rabbit secondary IgG
(1:1000), and protein signals were visualized by chemilu-
minescence (Immun-Star HRP detection kit; Bio-Rad).
Normalized values were then expressed as the ratio of
PER1 to tubulin or PER2 to tubulin protein expression.
Loose Patch Recording
Methods used were similar to those described previously
(Kudo et al., 2013). At ZT 4, slices were placed in a rec-
ording chamber attached to the stage of a fixed-stage
upright differential interference contrast (DIC) micro-
scope (Olympus, Center Valley, PA) and washed out
with perfusion system until ZT 5. When the recoding
was performed before ZT 5, the SCN slices were moved
to a recording chamber and SFR was recoded (see
Supplemental Figure 1 for protocol shown as electro-
physiology 1). Using the voltage-clamp recording tech-
nique in the loose-patch configuration, we measured the
SFR in SCN neurons. Each of these cells was determined
to be within the dorsal region of the SCN by direct visu-
alization of the location of the cell with infrared DIC
microscopy. Recordings (1min) were made during the
day (ZT 4–8, 2–6 h after the treatment, and 0–4 h after
washout). The slices were superfused continuously
(2mlmin1) with ACSF [in mM; 26 NaHCO3, 1.25
NaH2PO4, 10 glucose, 125NaCl, 3KCl, 2MgCl2,
2CaCl2, pH 7.2–7.4 (290–310mosmol kg
1)] aerated
with 95% O2–5% CO2. The loose-patch recordings
from the dorsal SCN (dSCN) were taken with recording
electrodes. We focused on this region of the SCN as the
rhythms in electrical activity are more robust in this
region of the SCN (Schaap et al., 1999). Micropipettes
(3–5M) were pulled from glass capillaries (WPI,
Sarasota, FL) on multistage puller (P-97; Sutter
Instruments, Novato, CA) and filled with the ACSF solu-
tion. Recordings were obtained with Axopatch 200B
amplifier (Molecular Devices, Sunnyvale, CA) and moni-
tored online with pClamp (version 10.3, Molecular
Devices). To minimize changes in offset potentials with
changing solutions, the ground path used a KCl agar
bridge. Each of the cells was determined to be within
the SCN by direct visualization of the location of the
cell with infrared (IR) DIC microscopy. All recordings
were performed at room temperature during ZT 4 to
ZT 8. Recordings were sampled at 10 kHz and filtered
at 1 kHz. After the 1-min recordings in gap-free mode,
the number of spike was counted. For some experiments,
the ACSF perfusion solution containing Gabazine
(20 mM) to block GABAA-mediated currents was applied
in the bath for 5min using bath application, and changes
in SFR were measured. In some cases, SFR was calcu-
lated by the determining the mean SFR for all of the
neurons recorded from that animal.
Whole Cell Patch Recording
Methods used were similar to those described previously
(Kudo et al., 2014). Using the whole cell patch configur-
ation, we measured electrical property in SCN neurons
(see Suplemental Figure 1 for protocol shown as electro-
physiology 2). Each of these cells was determined to
be within the dorsal region of the SCN by direct visual-
ization of the location of the cell with infrared DIC
microscopy. Recordings were made during the day (ZT
5–7, 3–5 h after the treatment, and 1–3 h after washout).
Slices were placed in a recording chamber (PH-1, Warner
Instruments) attached to the stage of a fixed-stage upright
IR DIC microscope (Olympus). The slices were super-
fused continuously (2ml min1) with ACSF aerated
with 95% O2–5% CO2. The whole cell patch-clamp
recordings from the dSCN were taken with recording
electrodes. These micropipettes (typically 7–9M) were
pulled from glass capillaries (WPI) on a multistage puller
(Sutter Instruments) and filled with the standard solution.
The standard solution contained (in mM) 112.5K-gluco-
nate, 1 EGTA, 10 HEPES, 5Mg ATP, 1 GTP, 0.1 leu-
peptin, 10 phosphocreatine, 4NaCl, 17.5KCl, 0.5CaCl2,
and 1MgCl2. We calculated the free [Ca
2þ] concentration
(Maxchelator software, Stanford University) to be
142 nM in the internal pipette solution. The pH was
adjusted to 7.20–7.30, and the osmolality was adjusted
between 290 and 300 mOsm. Recordings were obtained
with an Axopatch 200B amplifier (Molecular Devices)
and monitored online with pClamp (Clampex version
10.3, Molecular Devices). Each of the cells was deter-
mined to be within the dorsal region of the SCN by
direct visualization of the cell’s location with DIC micros-
copy. Cells were approached with slight positive pressure.
The pipette was lowered to the vicinity of the mem-
brane while maintaining positive pressure. After a high-
resistance seal (2–10G) was formed by application of
negative pressure, a second pulse of negative pressure was
used to break the membrane.
The access resistance of these cells ranged from 15 to
50M in the whole cell voltage-clamp configuration,
while the cell capacitance was typically between 6 and
18 pF. Data were not collected if access resistance was
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>50M or if the value changed significantly (>20%)
during the course of the experiment. The junction poten-
tials between the pipette and the extracellular solution
were canceled by the voltage offset of the amplifier
before a seal was established and were not further
corrected. Series and input resistance were monitored
repeatedly by checking the response to small pulses in a
passive potential range. Series resistance was not compen-
sated, and the maximal voltage error that was due to this
resistance was calculated to be 6mV. The standard extra-
cellular solution used for all experiments was ACSF.
Recordings were sampled at 10 kHz and filtered at
1 kHz. Resting membrane potential was measured by
averaging 1min recording under TTX application. For
current injection experiments, SFRs were measured in
current clamp mode for 1min at first. Next, 1min
square depolarizing current (5 pA) was injected to exam-
ine the effects of depolarization on SFR. When the mem-
brane resistance is 1G, this current injection causes a
5mV depolarization. After current injection, SFRs were
recorded without current injection. Totally, 352 cells were
recorded from 325 mice.
Measurement of Specific Ion Currents
Mouse SCN slices were made with the same method
described earlier. Using the whole cell patch configur-
ation, we measured electrical property in SCN neurons
(see Supplemental Figure 1 for protocol shown as
electrophysiology 2). Each of these cells was determined
to be within the dorsal region of the SCN by direct visu-
alization of the location of the cell with infrared DIC
microscopy. Recordings were made during the day (ZT
5–7, 3–5 h after the treatment, and 1–3 h after washout).
Drug treatments were performed by dissolving pharma-
cological agents in the ACSF used to bathe the slices
during recording. Solution exchanges within the slice
were achieved by a rapid gravity-feed delivery system.
For FDR and IA potassium currents, 1,2-bis(o-amino-
phenoxy)ethane-N,N,N0,N0-tetraacetic acid (BAPTA,
1mM) was added to the internal solution to buffer
[Ca2þ]i and inhibit [Ca2þ]i-dependent potassium currents
(Itri et al., 2010; Kudo et al., 2013). For the BK currents,
minimal EGTA (0.5mM) [Ca2þ]i buffering of the internal
solution was used to preserve [Ca2þ]i influences, because
BK currents is substantially influenced by [Ca2þ]i concen-
tration and Ca2þ fluxes through voltage-gated Ca2þ
channels (Pitts et al., 2006).
Methods utilized for FDR currents were similar to
those described previously (Itri et al., 2010). The FDR
Kþ currents were isolated pharmacologically with a vol-
tage-step protocol in the whole cell voltage-clamp config-
uration with the neurons initially held at 70mV. The
protocol consisted of a 100-ms prepulse at 90mV
(to elicit maximal conductance) followed by 250-ms
steps at progressively depolarized potentials (80 to
50mV, 10-mV steps). Current traces were recorded with
pClamp software (Molecular Devices) with the whole cell
voltage clamp recording configuration and then analyzed
with Clampfit (Molecular Devices). Leak subtraction was
performed during acquisition with a p/4 protocol, which
utilizes four subpulses with one fourth the test pulse
amplitude and reversed polarity given from a holding
potential of 70mV. Current traces from treatment
were subtracted from control to isolate FDR currents.
4-Aminopuyridine (4-AP, 0.5mM) and tetraethylammo-
nium (1mM) were used to isolate FDR currents. Current
measurements were performed in control solution and
after 5min drug treatment in each cell. The ACSF perfu-
sion solution contained Gabazine (20mM) to block
GABAA-mediated currents, cadmium (100mM) to block
calcium channels, TTX (2 mM) to block fast voltage-
activated sodium channels.
Methods utilized for IA currents were similar to those
described previously (Itri et al., 2010). To isolate IA cur-
rents in SCN neurons, two voltage-step protocols were
used in the whole cell patch-clamp configuration. The
first protocol consisted of a 100-ms prepulse at 90mV
(to elicit maximal conductance) followed by a 250-ms
step at progressively depolarized potentials (80 to
50mV, 5-mV steps). The second protocol consisted of a
100-ms prepulse at 50mV (to remove the contribution
of the IA current) followed by a 250-ms step at progres-
sively depolarized potentials (80 to 50mV, 5-mV steps).
Current traces from the second protocol were subtracted
from the first to isolate IA currents. The ACSF perfu-
sion solution contained Gabazine (20mM), cadmium
(100mM), TTX (2 mM).
Methods utilized for BK currents were similar to those
described previously (Pitts et al., 2006). SCN neurons
were voltage clamped at 60mV and steady sate I–V
curves were obtained at least 4min after first obtaining
a whole cell recording by stepping the potential from
100mV to 80mV at 20mV increments using 180ms
steps. The ACSF perfusion solution contained Gabazine
(20mM), cadmium (100mM), TTX (2mM), and 4-AP
(10mM) to block FDR and IA currents. Iberiotoxin
(IbTX, 100 nM), a specific BK channel blocker (Galvez
et al., 1990; Leonard et al., 1992; Giangiacomo et al.,
1993; Garcia et al., 1997), was then added. Additional
I–V curves were obtained 5min later to measure the
effect of IbTX on membrane currents. After the record-
ings, the washout was well performed for the next record-
ing. All recordings were performed at room temperature.
The currents were normalized by capacitance.
[Ca2þ]I Imaging
Methods used were similar to those described previously
(Colwell, 2000). At ZT 4, the medium change was
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performed to wash drugs (see Supplemental Figure 1 for
protocol shown as Ca2þ imaging). To load the dye into
cells, membrane-permeable Fura2 acetoxymethyl (final
concentration 50 mM, Thermo Fisher Scientific) was
added to the SCN in the 35mm dish and incubated at
34C for 40min at ZT 4 (5% CO2 incubator). After that
the slices were placed in a perfusion chamber (Warner
Instruments) and superfused (2ml min1) with ACSF
(room temperature) for 20min. Slices were constantly
oxygenated with 95% O2–5% CO2. The measurements
were made between ZT 5 and ZT 7.
A cooled CCD camera (CoolSNAP ES, 1392 1040
pixel format, Photometrics, Tucson, AZ) was added to
the fixed-stage microscope (BX50, Olympus) to measure
fluorescence. The fluorescence of Fura2 was excited alter-
natively at wavelengths of 357 nm and 380 nm by means
of a high-speed wavelength-switching device (Lambda
DG-4; Sutter Instruments). Image analysis software
(MetaFluor, Thermo Fisher Scientific) allowed the selec-
tion of several regions of interest within the field from
which measurements are taken. To minimize bleaching,
the intensity of excitation light and sampling frequency
was kept as low as possible. Measurements were normally
made once every 2 sec.
Free [Ca2þ] was calculated from the ratio (R) of fluor-
escence at 357 and 380 nm, using the following equation:
[Ca2þ]¼KdSf (RRmin)/(RmaxR) (Grynkiewicz
et al., 1985). The value of Kd was assumed to be
135 nM, while values for Rmin and Rmax were all deter-
mined via in vitro calibration methods (Molecular
Probes). Once the calibrations were made, the camera
settings were then fixed and measurements were made
with 380 nm and 357 nm excitation of the solutions.
Real-Time Monitoring of Bioluminescence
Methods used were similar to those described previously
(Nakamura et al., 2011). Mouse SCN slices were made
with the same method described earlier. At ZT 4, the
medium change was performed to wash drugs. Explants
were transferred on to Millicell membranes (0.4 mm,
PICMORG50, Merck KGaA) resting on 1.2ml of rec-
ording media that contained freshly added 0.1mM luci-
ferin (sodium salt monohydrate, Biosynth Chemistry &
Biology, Itasca, IL), and the 35mm dishes were sealed
using autoclaved high-vacuum grease (Dow Corning,
Midland, Michigan). Tissue explants were inserted in
the LumiCycle photomultiplier tube (Actimetrics,
Wilmette, IL), and bioluminescence was monitored at
37C. The bioluminescence signal was counted in 1min
bins for every 10min for at least 5 days without changing
media. The data were normalized by subtraction of the
24 h running average from the raw data and then
smoothed with a 2 h running average (LumiCycle ana-
lysis, Actimetrics).
Drugs
4-AP, TTX, cadmium chloride, and IbTX were pur-
chased from Sigma-Aldrich (St. Louis, MO). Gabazine
(SR 95531 hydrobromide) was purchased from Tocris
(Bristol, UK). For Per1 gene knock down, either anti-
sense ODN sequence against the 50 translational start
site of Per1 (taggggaccactcatgtct; Sigma-Aldrich) or a
random ODN with equivalent GC content (ccgttagtact
gagctgac) was applied at a final concentration of 10 mM
from ZT 2 to ZT 4. These antisense ODN and random
ODN were previously used (Akiyama et al., 1999;
Wakamatsu et al., 2001; Tischkau et al., 2003; Marquez
et al., 2004; Koyanagi et al., 2006; Gamble et al., 2007;
Kudo et al., 2013). While siRNA can be a more efficient
method, there are problems of transfection efficiency
while the ODN method to reduce Per1 has been estab-
lished in the SCN slices (Gamble et al., 2007; Kudo et al.,
2013). The antisense ODN is incorporated into cells by
endocytosis. The antisense ODN was applied from ZT 2
to ZT 4, because the SCN slices was moved from 35-mm
culture dish to the perfusion chamber. In the perfusion
chamber, the flow rate is 2mlmin1 and it is cost pro-
hibitive to continually apply antisense ODN through the
perfusion system.
Statistical Analysis
The data sets were analyzed by test for equal variance and
normal distribution to help select the appropriate test.
The data sets were analyzed by one-way, two-way, or
two-way repeated-measures ANOVA. If significant
group differences were detected by the ANOVA, then a
post hoc analysis was applied. Statistical significances
between two groups were determined by Student’s
t-test. If equal variance and normal distribution tests
were failed, Mann-Whitney U test was performed.
Equal variance test was performed to check variances
of SFR. Values were considered significantly different if
p< .05. All tests were performed with SigmaPlot (version
12, Systat Software, Chicago, IL). Values are shown as
means SE or þSE.
Results
Antisense ODN Against Per1 Reduced PER1
Expression
To confirm the effectiveness of the antisense ODN against
Per1, we used IHC to measure PER1 expression in the
SCN brain slice (protocol shown in Supplemental
Figure 1). The SCN was fixed at ZT 2, 3, 4, 5, and 6,
and PER1 expression was examined. We applied two-way
ANOVA, and there were main effects of time, F(4,
30)¼ 22.321, p< .01, and treatment, F(2, 30)¼ 7.337,
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p< .01, but there were no interactions of time x treat-
ment, F(8, 30)¼ 1.588, not significant (n.s.). The applica-
tion of antisense ODN for Per1 (10mM) at ZT 2
significantly reduced the number of PER1 expressing
cell in the SCN at ZT 5 (Figure 1(a), two-way ANOVA
followed by Holm-Sidak method for multiple compari-
sons, vs. Cont, p< .05). At ZT 5, we found that the
number of PER1 expressing neurons was reduced by
approximately 50% (Cont: 101 17 PER1 positive
cells/slice, Anti: 50 7). Optical density measurements
revealed a similar level of decreased expression (Cont:
876 67 arbitrary unit, Anti: 470 73 arbitrary unit;
unpaired Student’s t-test: p< .05). In contrast, the
scrambled ODN did not alter PER1 expression (two-
way ANOVA followed by Holm-Sidak method for mul-
tiple comparisons, n.s.). As a control for the specificity of
the antisense ODN against Per1, we also examined PER2
expression at ZT 5. We found no change in this closely
related protein in the SCN (Cont: 34 7 PER2 positive
cells/slice; Treated: 31 3; unpaired Student’s t-test, n.s.).
To further analyze the clock gene expression, Western
blots were performed (protocol shown in Supplemental
Figure 1). As for PER1, there was significant main effects
(one-way ANOVA, F(2, 6)¼ 3.605, p< .05) and again,
antisense ODN against Per1 significantly reduced the
PER1 expression in the SCN (Figure 1(b), one-way
ANOVA followed by Holm-Sidak, F(2, 6)¼ 3.905,
p< .05) without altering PER2 expression (Figure 1(c),
one-way ANOVA, F(2, 6)¼ 0.0611, n.s.). These results
confirmed that antisense ODN for Per1 is specifically
suppresses PER1 protein expression.
Antisense ODN Against Per1 Reduced SFR in dSCN
Neurons During the Day
To examine the impact of the transient reduction of
PER1 on the electrical activity in the SCN, we sampled
SFR in dSCN neurons at different time points (2–6 h)
after the end of the ODN treatment (ZT 2–4;
Supplemental Figure 1, electrophysiology 1). Two-way
ANOVA revealed significant differences of main effects
(time: F(3, 259)¼ 10.101, p< .01, treatment: F(2,
259)¼ 7.975, p< .01). Also there was significant inter-
action between TimeTreatment (F(6, 259)¼ 2.842,
p< .05). The antisense ODN treatment caused a signifi-
cant reduction in SFR at ZT 5.5 and 6.5 (Figure 2(a) and
(b), two-way ANOVA followed by Holm-Sidak method
for multiple comparisons, vs. Cont, ZT 5.5: p< .05, ZT
6.5: p< .05). The SFR returned to control level by 3.5 h
after the treatment ended (ZT 7.5). In PER1 protein
levels, time course of PER1 reduction showed lowest
level at ZT 5, but PER1 level returned to control level
at ZT 6. On the other hand, SFR was lower at ZT 5.5–
6.5. Scrambled ODN did not alter the SFR at any time
(Figure 2(a) and (b); two-way ANOVA followed by
Holm-Sidak method, n.s.). This analysis assumes that
every neuron is independent as is typically for electro-
physiological recordings. We also examined the impact
of the antisense treatment by averaging all of the values
for the individual neurons to come up with an average
SFR per mouse. Here too, we found that the antisense
ODN significantly reduced SFR (Cont: 4.4 0.2Hz,
n¼ 8 mice, anti: 3.1 0.4, n¼ 8 mice, unpaired
Student’s t-test, p< .05). We examined resting membrane
potential of dSCN neurons during ZT 5 to 7 and found
that the membrane potential was significantly hyperpo-
larized in Per1 antisense-treated group (Figure 2(c),
unpaired Student’s t-test, p< .05, Cont: 40 cells from 30
mice, 40.5 1.7mV, anti: 40 cells from 37 mice,
46.2 1.5mV).
Next, we sought to determine if direct current injection
into SCN neurons could overcome the decreased SFR
observed under antisense treatment. Using the current-
clamp recording technique in the whole cell patch config-
uration, we performed current injections in dSCN neu-
rons. For these experiments, SFRs were measured in
current clamp mode for 1min at first. Next, 1min
square depolarizing current (5 pA) was injected to exam-
ine the effects of depolarization on SFR. When the mem-
brane resistance is 1G, this current injection causes a
5mV depolarization. After current injection, SFRs were
recorded without current injection. The results were
mixed. Most cells (7 cells, 70%) exhibited a dramatic
increase in firing (>140%) by the current injection
(5 pA), but some cells (3 cells, 30%) did not respond
(Figure 2(d) and (e)). This suggests that a specific ionic
mechanism may be altered by the antisense ODN for
Per1. These results demonstrate that most antisense-
treated neurons still had the capacity to fire action poten-
tials at the normal frequency.
If the suppression of transcription and translation of
Per1 is critical for SFR regulation, broad transcriptional
and translational inhibitors should produce the same
effects. Therefore, we examined the effects of broad tran-
scriptional (Actinomycin D) and translational (cyclohexi-
mide) inhibitors using the same protocol (Supplemental
Figure 1). Both Actinomycin D and cycloheximide signifi-
cantly reduced the SFR in the SCN during day (Figure
2(f), Kruskal-Wallis ANOVA on ranks followed by
Dunn’s method, H3¼ 31.272, Actinomycin D: p< .05 vs.
Cont, cycloheximide: p< .05 vs. Cont). These results indi-
cate that global transcriptional and translational inhibitors
mimicked the effects of antisense ODN for Per1 on SFR.
To determine whether the circadian phase was shifted
by antisense ODN, we examined the effects of antisense
on the rhythm in PER2::LUC in SCN explants. We
found that the reduction in PER1 did not result in sig-
nificant phase shifts measured in the next day (Cont: pro-
jected ZT (pZT) 10.5 1.2, n¼ 8, Anti: pZT13.5 1.1,
n¼ 8, unpaired Student’s t-test, n.s.).
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Figure 2. Antisense ODN for Per1 reduced firing rate in dorsal SCN neurons during the day. (a) Representative examples illustrating the
reduced firing rates by the antisense ODN for Per1 (10 mM). Cont: control, Anti: antisense ODN for Per1, and Scr: scrambled ODN. (b)
Average firing rate for each group ( SE). *Significant difference (p< .05) analyzed by two-way ANOVA followed by Holm-Sidak method
for multiple comparisons (vs. Cont). For each group n¼ 17–28 cells from 4 mice at each time point (in total, 271 cells from 48 mice). (c)
Average resting membrane potential for each group ( SE). *Significant difference (p< .05) analyzed by unpaired Student’s t-test. For each
group, n¼ 40 cells from 30 to 37 mice. (d) Representative examples illustrating the effects of current injections on SFR under antisense
ODN for Per1. (e) Average firing rate for each group (SE). *Significant difference (p< .05) analyzed by two-way repeated measures
ANOVA followed by Holm-Sidak method for multiple comparisons (vs. Cont). For each group, n¼ 10 cells from 7 to 9 mice. (f) Effects of
actinomycin D and cycloheximide (CHX) on SFR in the SCN during daytime. Actinomycin D solution (0.8 mM final concentration), CHX
(final 36 mM), or water (as a control) was added to the culture medium 3 h before the start of recordings. The SFR was measured by loose-
patch method. Average firing rate for each group (SE). *Significant difference (p< .05) analyzed by one-way ANOVA followed by Dunn’s
method for multiple comparisons (vs. Cont). For each group, n¼ 30–51 cells from 4 to 8 mice. Cont and Anti data are the same as (b).
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Antisense ODN Against Per1 Reduced [Ca2þ]i
Levels in Cell in the SCN During Daytime
In SCN neurons, changes in electrical activity are directly
reflected in changes in [Ca2þ]i levels (Irwin and Allen,
2013). Using [Ca2þ]i imaging techniques and the same
protocol as described earlier, we evaluated the impact
of reducing PER1 on resting [Ca2þ]i levels in SCN neu-
rons (protocol shown in Supplemental Figure 1). We
found [Ca2þ]i levels in the SCN neurons treated with
the antisense ODN were significantly reduced (Mann-
Whitney U test, p< .05) compared with Cont
(Figure 3). We estimated the resting [Ca2þ]i levels to be
135 11 nM in Cont and 98 6 nM in the treated neu-
rons. Thus, we confirmed that reducing PER1 leads to
lower [Ca2þ]i levels in SCN neurons.
Antisense ODN Against Per1 Reduced BK Currents
in the SCN during Daytime
A set of voltage-gated potassium currents controls the
SFR of SCN neurons (Colwell, 2011) and we sought to
identify the specific potassium currents that are altered by
the reduction of PER1. Whole cell patch clamp recordings
were used to measure FDR, IA, and BK currents in the
SCN during the day (ZT 5–7; protocol shown in
Supplemental Figure 1). Each of these three currents has
been suggested to have a role in the modulation of SFR in
SCN neurons during the daytime. Antisense ODN against
Per1 did not alter the magnitude of the FDR (Figure 4(a),
two-way repeated measures ANOVA, main effects; treat-
ment: n.s.) or IA currents (Figure 4(b), FDR: two-way
repeated measures ANOVA, main effects; treatment:
n.s.). Importantly, the treatment did significantly reduce
the magnitude of the BK current (Figure 4(c)). Two-way
repeated measures ANOVA revealed main effects of an
interaction of TreatmentVoltage (F(9, 441)¼ 3.112,
p< .01). Antisense ODN against Per1 significantly reduced
the magnitude of BK currents at 60mV (post hoc: Holm-
Sidak, p< .05, vs. Cont), 80mV (Holm-Sidak, p< .05, vs.
Cont). Finally, we examined if BK currents blocker IbTX
effects on the SFR in the SCN. The application of the BK
blocker IbTX reduced daytime SFR to a similar degree as
the antisense ODN (Figure 4(d), one-way ANOVA fol-
lowed by Dunn’s method, p< .05, vs. Cont). There was
no significant differences in the variance of SFR recorded
between antisense and IbTX-treated groups (equal vari-
ance test, F¼ 2.19, p¼ .08). These results indicate that
the antisense ODN for Per1 rapidly and selectively reduces
the BK current in the SCN.
Discussion
Per1 is one of the core clock genes expressed in high levels
in the mouse SCN (Sun et al., 1997; Tei et al., 1997). The
Per1mRNA levels exhibit a robust circadian rhythm with
transcript levels starting to rise near dawn and peak
expression in the middle of day (CT 6–8). The protein
is delayed a few hours with PER1 protein peaking
around CT 10 in the mouse SCN (LeSauter et al.,
2003). In the present study, we demonstrate that antisense
ODN application during the rising phase of protein levels
(ZT 2–4) was able to transiently reduce PER1 levels for
2 h (Figure 1). The treatment was selective and did not
alter levels of the closely related PER2 (Figure 1). The
transient knock down of PER1 was not sufficient to alter
the phase of the molecular clockwork as measured by
PER2::LUC bioluminescence. This enabled us to exam-
ine, for the first time, the impact on the membrane of
transiently reducing PER1 in SCN neurons. The finding
is important as it shows that the transient reduction of
Figure 3. Antisense ODN for Per1 reduced [Ca2þ]i levels in cells in the SCN during daytime. In these experiments, resting [Ca2þ]i levels
were estimated in SCN neurons in brain slices with antisense ODN for Per1 and compared with data obtained from the control group.
Animals were sacrificed at ZT 0. Each cell is sampled only once. Left: Representative pictures in Fura2 imaging in the SCN. Right: Dot
density plot showing that [Ca2þ]i levels in SCN cells were reduced by antisense ODN for Per1. Cont: control, Anti: antisense ODN for
Per1. *Significant difference (p< .05) analyzed by unpaired Student’s t-test. Bottom: Histograms illustrating the distribution of [Ca2þ]I levels.
For each group (SE), n¼ 59 cells from four mice.
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Figure 4. Antisense ODN for Per1 reduced BK currents in the SCN during daytime. (a) Left, representative examples showing that
application of antisense ODN for Per1 (10 mM) did not decrease the magnitude of fast delayed rectifier (FDR) currents in the SCN neurons.
Right, current-voltage (I–V) relationship of FDR currents in SCN neurons. Cont: control, Anti: antisense ODN for Per1. For each group
(SE), n¼ 20 cells from 10 mice. (b) Left, representative examples showing the IA currents. Right, I–V curve of IA measured in SCN
neurons. For each group (SE), n¼ 11–15 cells from 4 to 13 mice. (c) Left, representative examples showing BK currents. Right, I–V curve
of BK current measured in SCN neurons. *Significant difference (p< .05) analyzed by two-way repeated measures ANOVA followed by
Holm-Sidak method for multiple comparisons (vs. Cont). For each group (SE), n¼ 20–21 cells from 15 to 18 mice. (d) Average firing rate
of control, antisense ODN for Per1, and iberiotoxin (IbTX). *Significant difference (p< .05) analyzed by one-way ANOVA followed by
Dunn’s method for multiple comparisons (vs. Cont). For each group n¼ 12–51 cells from 6 to 8 mice. Cont and Anti data are the same as
Figure 2(b). The currents were normalized by capacitance.
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this clock gene rapidly impacts membrane events. It fits
with the prior observation that the Per1 KO mice show
arrhythmic or low amplitude rhythms in clock gene expres-
sion (Pendergast et al., 2009). Both of these results stand in
contrast to the in vivo analysis of the Per1 mutants that
show normal rhythms in wheel running behavior and SCN
neural activity rhythms (Pendergast et al., 2009; Takasu
et al., 2013). The difference in effect between in vitro and
in vivo analysis is becoming a common theme in circadian
rhythms research where the SCN circadian clock has been
shown to be quite resilient and has both genetic (DeBruyne
et al., 2007) and circuit level (Liu et al., 2007) mechanisms
to protect against mutations. Part of the appeal of the
rapid antisense approach is that it circumvents the possi-
bility of genetic compensation.
We found that antisense ODN treatment caused a
transient reduction (2–3 h) in SFR (Figure 2(a) and (b)).
When PER1 expression (Figure 1(a) and (b)) and SFR
(Figure 2(f)) are compared, the variability of the SFR is
relatively large. In our work, we are measuring PER1
expression in the whole SCN but measuring SFR from
single neurons. Prior work has shown that there is a cor-
relation between Per1 levels and electrical activity in
single SCN neurons. In Per1::GFP mice, the temporal
dynamics of transcriptional activation of Per1 can be
optically followed by monitoring green fluorescent pro-
tein (GFP) fluorescence. In these mice, there is a direct
correlation between the frequency of action potentials
and the level of Per1 expression in SCN neurons
(Kuhlman et al., 2003; Quintero et al., 2003). It is not
clear whether Per1 expression is correlated to the SFR
per se or more directly a reflection of the underlying
membrane depolarization as another study using the
same mice reported a high GFP signal in SCN neurons
that were so depolarized as to be unable to generate
action potentials (Belle et al., 2009).
Our hypothesis is that circadian rhythms in electrical
activity are driven, in part, through rhythmic changes in
Per1 expression. This hypothesis is supported by our
observation that transient decreases in PER1 levels
result in a reduction in SFR. However, the relationship
between Per1 expression and membrane potential may be
complex in that studies at a population level reveal that
membrane hyperpolarization, by lowering the extracellu-
lar concentration of Kþ in SCN cultures, reversibly
abolishes the rhythmic expression of Per1 (Lundkvist
et al., 2005). These studies, along with work in
Drosophila (Nitabach et al., 2002; Sheeba et al., 2008),
suggest that electrical activity of pacemaker neurons
impacts the molecular clockwork, and that keeping
SCN cells in an appropriate voltage range may be
required for the generation of circadian rhythmicity of
clock gene expression at the single-cell level. Thus, the
relationship between Per1expression and membrane
potential may be bidirectional.
Our findings raise new questions about the underlying
mechanism by which reducing PER1 could alter mem-
brane activity within hours. While changes in trafficking
or posttranslational modifications of ion channels seem
to offer a likely mechanistic explanation, we found that
broad spectrum inhibitors of both transcription and
translation mimicked the impact of the antisense ODN
treatment (Figure 2(f)). Most of the SCN neurons still
had the capacity to generate action potentials at the
normal firing rate as direct current injection increased
SFR in some but not all of the neurons (7 out of 10
SCN neurons tested; Figure 2(d) and (e)). Next we went
on to examine [Ca2þ]i levels within SCN neurons. SCN
neurons show a clear [Ca2þ]i rhythm (Colwell, 2000;
Enoki et al., 2012; Brancaccio et al., 2013) which, like
the electrical activity, is high during daytime and low
during nighttime. The antisense ODN treatment caused
a reduction in resting [Ca2þ]i during the middle of the day
(Figure 3). Presently, we do not know whether the reduc-
tion in [Ca2þ]i occurs prior to the impact on electrical
activity or whether the decrease in electrical activity
drives the reduced [Ca2þ]i. There is evidence that the
core clock protein Cryptochrome can alter the cAMP
signaling cascade through an interaction with G-proteins
(Zhang et al., 2010), so it is possible that PER1 could
have a similar role in the [Ca2þ]i regulatory process.
A set of voltage-gated potassium currents control the
SFR of SCN neurons (Colwell, 2011). We sought to iden-
tify the specific Kþ currents that are altered by the reduc-
tion of PER1 using whole-cell patch clamp recordings.
The magnitudes of both the FDR (Itri et al., 2005;
Kudo et al., 2011) and IA (Itri et al., 2010; Granados-
Fuentes et al., 2012) currents vary with the circadian
cycle and are important regulators of SCN SFR during
the day. However, our data demonstrate that neither of
these currents is altered by the reduction in PER1
(Figure 4). In contrast, the BK currents were significantly
reduced. Prior work has shown that the BK current is
important for SFR in SCN neurons (Pitts et al., 2006;
Kent and Meredith, 2008; Montgomery and Meredith,
2012) and expression of rhythmic behavior (Meredith
et al., 2006). The gene that encodes the pore-forming sub-
unit of the BK channel (Kcnma1) and the BK channel are
rhythmically expressed in the SCN (Panda et al., 2002;
Meredith et al., 2006; Pitts et al., 2006). This body of
work suggests that the BK current is important for both
the nocturnal hyperpolarization in SCN neurons but also
for the regulation of daytime firing rate (see Montgomery
and Meredith, 2012). We confirmed that blocking the BK
channel with IbTX mimics the effect of the antisense
(Figure 4) as has been previously reported (Pitts et al.,
2006). Therefore, our results support a model in which
PER1 regulates expression of the BK current, either dir-
ectly or indirectly, through a mechanism dependent on
transcription and translation of proteins.
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The molecular clockwork that generates rhythms in
PER1 is widely expressed in the body including electric-
ally active cells in the islets, heart, and brain. There is a
lack of a mechanistic understanding of how this molecu-
lar feedback loop interacts with the membrane to produce
circadian rhythms in electrical activity that is important
for these cell populations. Clearly, the signals traveling to
and from this molecular feedback loop must travel
through the membrane, but it is not known how the
molecular feedback loop drives the rhythm in electrical
membrane processes. In the present study, we provide
evidence that the molecular clock regulates firing rate
and the magnitude of the BK current in SCN neurons.
Certainly, other currents are also impacted by the molecu-
lar clockwork, but here we provide a concrete example
that the reduction of PER1 rapidly alters a critical current
in the SCN. Our data provide new insights into the under-
lying mechanisms by which the molecular rhythmicity
ultimately impact mammalian physiology and behavior.
Ultimately, much of the work of the central nervous
system is affected through the generation and transmission
of electrical signals. Thus, it is critical to understand the
relationship between intracellular molecular feedback
loops giving rise to circadian rhythms and the transmission
of rhythmic electrical information throughout the nervous
system. Consequenctly, there are compelling reasons to
better understand the mechanisms underpinning the inter-
action between the molecular clock and electrical activity.
Summary
In this study, we demonstrate for the first time that tran-
siently and selectively reducing the levels of the clock gene
Period1 (Per1) decreases electrical activity in the mouse
SCN.
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